Intravenous ondansetron for the control of opioid-induced nausea and vomiting. International S3AA3013 Study Group.
Sussman G, Shurman J, Creed MR, Larsen LS, Ferrer-Brechner T, Noll D, Allegra J, Montgomery R, Schreck D, Grafstein E, Ramalanjaona G, Patel V, Ducharme J, Ortenwall P, Foster E, Ames M.
Sussman G, et al. Among authors: patel v.
Clin Ther. 1999 Jul;21(7):1216-27. doi: 10.1016/s0149-2918(00)80024-7.
Clin Ther. 1999.
PMID: 10463519
Clinical Trial.